A guide to the composition and functions of the extracellular matrix

Nikos K. Karamanos, Achilleas D. Theocharis, Zoi Piperigkou, Dimitra Manou, Alberto Passi, Spyros S. Skandalis, Demitrios H. Vynios, Véronique Orian‐Rousseau, Sylvie Ricard‐Blum, Christian E. H. Schmelzer, Laurent Duca, Madeleine Durbee, Nikolaos A. Afratis, Linda Troeberg, Marco Franchi, Valentina Masola, Maurizio Onisto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Extracellular matrix (ECM) is a dynamic 3‐dimensional network of macromolecules that provides structural support for the cells and tissues. Accumulated knowledge clearly demonstrated over the last decade that ECM plays key regulatory roles since it orchestrates cell signaling, functions, properties and morphology. Extracellularly secreted as well as cell‐bound factors are among the major members of the ECM family. Proteins/glycoproteins, such as collagens, elastin, laminins and tenascins, proteoglycans and glycosaminoglycans, hyaluronan and their cell receptors such as CD44 and integrins, responsible for cell adhesion, comprise a well‐organized functional network with significant roles in health and disease. On the other hand, enzymes such as matrix metalloproteinases and specific glycosidases including heparanase and hyaluronidases contribute to matrix remodeling and affect human health. Several cell processes and functions, among them cell proliferation and survival, migration, differentiation, autophagy, angiogenesis and immunity regulation are affected by certain matrix components. Structural alterations have been also well associated with disease progression. This guide on the composition and functions of the ECM gives a broad overview of the matrisome, the major ECM macromolecules and their interaction networks within the ECM and with the cell surface, summarizes their main structural features and their roles in tissue organization and cell functions, and emphasizes the importance of specific ECM constituents in disease development and progression as well as the advances in molecular targeting of ECM to design new therapeutic strategies.
Original languageEnglish
JournalFEBS Journal
Early online date19 Feb 2021
DOIs
Publication statusE-pub ahead of print - 19 Feb 2021

Cite this